New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
CMS-nir
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
Four Federal Efforts to Monitor, Including RESULTS Act Progress
Other proposals aim to increase fraud enforcement, temper prior authorization, and modernize CLIA
Already a member? Log in here
Medicare Reimbursement: The 5 Things Labs Need to Know about the 2022 Physician Fee Schedule
...
Already a member? Log in here
The 4 Things Labs Need to Know About the 2022 OPPS Payments Rule
...
Already a member? Log in here
CMS Repeals Rule Providing Expedited Medicare Coverage for MCIT “Breakthrough” Devices
...
Already a member? Log in here
CMS Delays Payer-to-Payer Data Exchange but Prior Authorization Rules Remain on Track
On Sept. 17,...
New LCD Expanding Medicare Coverage for Circulating Tumor Cells Tests Is a Win for Biocept
...
Already a member? Log in here
CMS Proposes to Ease but Not End Hospital Price Transparency
...
Already a member? Log in here
Congress Moves to Limit Prior Authorization Protocols of Medicare Advantage Plans
...
Already a member? Log in here
CMS Proposes to Ease, but Not End Hospital Price Transparency
...
Already a member? Log in here
MCIT Medicare Coverage Rule Could Be Reimbursement “Breakthrough” for Makers of LDTs
...
Already a member? Log in here